Jorge Cortes, MD, Augusta University, Augusta, GA, comments on the financial toxicity associated with therapies for hematological malignancies, emphasizing the importance of improving access to novel therapies for all patients. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.